论文部分内容阅读
目的:研究和探讨老年重度心力衰竭合并快速心律失常患者给予静脉注射胺碘酮治疗的临床疗效进行分析。方法:选取入住我院接并接受治疗的96例老年重度心力衰竭合并快速心律失常患者作为研究对象,以随机数字表法将其随机分为观察组和对照组,对照组使用内科治疗法,观察组是在此基础上在给予静脉注射胺碘酮治疗,比效两组患者在治疗前后的舒张压、收缩压及心率变化情况。结果:两组患者经治疗后舒张压、收缩压及心率的变化,观察组患者的舒张压、收缩压、心率与对照组对比,统计学上有意义(P<0.05)。结论:经对老年重度心力衰竭合并快速心律失常患者给予静脉注射胺碘酮治疗是一种安全有效的治疗方法,也是目前最理想的治疗方法,可在医学界推广应用。
Objective: To study and investigate the clinical efficacy of intravenous amiodarone in elderly patients with severe heart failure complicated with tachyarrhythmia. Methods: A total of 96 elderly patients with severe heart failure complicated with tachyarrhythmia admitted to our hospital were enrolled in this study. Patients were randomly divided into observation group and control group with random number table method. The control group was treated with medical therapy. Group is on the basis of intravenous amiodarone given intravenous injection, the two groups of patients with effective than before and after treatment of diastolic blood pressure, systolic blood pressure and heart rate changes. Results: The changes of diastolic blood pressure, systolic blood pressure and heart rate after treatment in both groups were statistically significant (P <0.05). The diastolic blood pressure, systolic blood pressure and heart rate in the observation group were statistically significant (P <0.05). Conclusion: It is a safe and effective treatment for intravenous amiodarone in elderly patients with severe heart failure and tachyarrhythmia. It is also the most ideal treatment and can be widely applied in the medical field.